The role of S100A4 for bone metastasis in prostate cancer cells

Abstract Background Prostate cancers frequently metastasize to bone, where the best microenvironment for distant colonization is provided. Since osteotropic metastasis of prostate cancer is a critical determinant of patients’ survival, searches for preventive measures are ongoing in the field. There...

Full description

Bibliographic Details
Main Authors: Bongjun Kim, Suhan Jung, Haemin Kim, Jun-Oh Kwon, Min-Kyoung Song, Min Kyung Kim, Hyung Joon Kim, Hong-Hee Kim
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-07850-4
_version_ 1818623199490867200
author Bongjun Kim
Suhan Jung
Haemin Kim
Jun-Oh Kwon
Min-Kyoung Song
Min Kyung Kim
Hyung Joon Kim
Hong-Hee Kim
author_facet Bongjun Kim
Suhan Jung
Haemin Kim
Jun-Oh Kwon
Min-Kyoung Song
Min Kyung Kim
Hyung Joon Kim
Hong-Hee Kim
author_sort Bongjun Kim
collection DOAJ
description Abstract Background Prostate cancers frequently metastasize to bone, where the best microenvironment for distant colonization is provided. Since osteotropic metastasis of prostate cancer is a critical determinant of patients’ survival, searches for preventive measures are ongoing in the field. Therefore, it is important to dissect the mechanisms of each step of bone metastasis, including the epithelial-mesenchymal transition (EMT) and cross-talk between metastatic niches and cancer cells. Methods In this study, we established a highly bone-metastatic subline of human prostate cancer cells by selecting bone-homing population of PC3 cells after cardiac injection of eight-week-old male BALB/c-nude mice. Then we assessed the proliferation, EMT characteristics, and migration properties of the subline (mtPC3) cells in comparison with the parental PC3 cells. To investigate the role of S100A4, we performed gene knock-down by lentiviral transduction, or treated cells with recombinant S100A4 protein or a S100A4-neutralizing antibody. The effect of cancer cells on osteoclastogenesis was evaluated after treatment of pre-osteoclasts with conditioned medium (CM) from cancer cells. Results The mtPC3 cells secreted a markedly high level of S100A4 protein and showed elevated cell proliferation and mesenchymal properties. The increased proliferation and EMT traits of mtPC3 cells was inhibited by S100A4 knock-down, but was not affected by exogenous S100A4. Furthermore, S100A4 released from mtPC3 cells stimulated osteoclast development via the cell surface receptor RAGE. Down-regulation or neutralization of S100A4 in the CM of mtPC3 cells attenuated cancer-induced osteoclastogenesis. Conclusion Altogether, our results suggest that intracellular S100A4 promotes cell proliferation and EMT characteristics in tumor cells, and that secreted S100A4 activates osteoclastogenesis, contributing to osteolytic bone metastasis. Thus, S100A4 upregulation in cancer cells highly metastatic to bone might be a key element in regulating bone metastasis.
first_indexed 2024-12-16T18:37:16Z
format Article
id doaj.art-6249fb7df8224bc4b5c1fd278ef86268
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-16T18:37:16Z
publishDate 2021-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-6249fb7df8224bc4b5c1fd278ef862682022-12-21T22:21:08ZengBMCBMC Cancer1471-24072021-02-0121111310.1186/s12885-021-07850-4The role of S100A4 for bone metastasis in prostate cancer cellsBongjun Kim0Suhan Jung1Haemin Kim2Jun-Oh Kwon3Min-Kyoung Song4Min Kyung Kim5Hyung Joon Kim6Hong-Hee Kim7Department of Cell and Developmental Biology, BK21 PLUS Program and DRI, School of Dentistry, Seoul National UniversityDepartment of Cell and Developmental Biology, BK21 PLUS Program and DRI, School of Dentistry, Seoul National UniversityArthritis and Tissue Degeneration Program, David Z. Rosensweig Genomics Research Center, Hospital for Special SurgeryDepartment of Cell and Developmental Biology, BK21 PLUS Program and DRI, School of Dentistry, Seoul National UniversityDepartment of Cell and Developmental Biology, BK21 PLUS Program and DRI, School of Dentistry, Seoul National UniversityDepartment of Cell and Developmental Biology, BK21 PLUS Program and DRI, School of Dentistry, Seoul National UniversityDepartment of Oral Physiology, BK21 PLUS Project, and Dental and Life Science Institute, School of Dentistry, Pusan National UniversityDepartment of Cell and Developmental Biology, BK21 PLUS Program and DRI, School of Dentistry, Seoul National UniversityAbstract Background Prostate cancers frequently metastasize to bone, where the best microenvironment for distant colonization is provided. Since osteotropic metastasis of prostate cancer is a critical determinant of patients’ survival, searches for preventive measures are ongoing in the field. Therefore, it is important to dissect the mechanisms of each step of bone metastasis, including the epithelial-mesenchymal transition (EMT) and cross-talk between metastatic niches and cancer cells. Methods In this study, we established a highly bone-metastatic subline of human prostate cancer cells by selecting bone-homing population of PC3 cells after cardiac injection of eight-week-old male BALB/c-nude mice. Then we assessed the proliferation, EMT characteristics, and migration properties of the subline (mtPC3) cells in comparison with the parental PC3 cells. To investigate the role of S100A4, we performed gene knock-down by lentiviral transduction, or treated cells with recombinant S100A4 protein or a S100A4-neutralizing antibody. The effect of cancer cells on osteoclastogenesis was evaluated after treatment of pre-osteoclasts with conditioned medium (CM) from cancer cells. Results The mtPC3 cells secreted a markedly high level of S100A4 protein and showed elevated cell proliferation and mesenchymal properties. The increased proliferation and EMT traits of mtPC3 cells was inhibited by S100A4 knock-down, but was not affected by exogenous S100A4. Furthermore, S100A4 released from mtPC3 cells stimulated osteoclast development via the cell surface receptor RAGE. Down-regulation or neutralization of S100A4 in the CM of mtPC3 cells attenuated cancer-induced osteoclastogenesis. Conclusion Altogether, our results suggest that intracellular S100A4 promotes cell proliferation and EMT characteristics in tumor cells, and that secreted S100A4 activates osteoclastogenesis, contributing to osteolytic bone metastasis. Thus, S100A4 upregulation in cancer cells highly metastatic to bone might be a key element in regulating bone metastasis.https://doi.org/10.1186/s12885-021-07850-4Prostate cancerBone metastasisS100A4Epithelial-mesenchymal transitionOsteoclast
spellingShingle Bongjun Kim
Suhan Jung
Haemin Kim
Jun-Oh Kwon
Min-Kyoung Song
Min Kyung Kim
Hyung Joon Kim
Hong-Hee Kim
The role of S100A4 for bone metastasis in prostate cancer cells
BMC Cancer
Prostate cancer
Bone metastasis
S100A4
Epithelial-mesenchymal transition
Osteoclast
title The role of S100A4 for bone metastasis in prostate cancer cells
title_full The role of S100A4 for bone metastasis in prostate cancer cells
title_fullStr The role of S100A4 for bone metastasis in prostate cancer cells
title_full_unstemmed The role of S100A4 for bone metastasis in prostate cancer cells
title_short The role of S100A4 for bone metastasis in prostate cancer cells
title_sort role of s100a4 for bone metastasis in prostate cancer cells
topic Prostate cancer
Bone metastasis
S100A4
Epithelial-mesenchymal transition
Osteoclast
url https://doi.org/10.1186/s12885-021-07850-4
work_keys_str_mv AT bongjunkim theroleofs100a4forbonemetastasisinprostatecancercells
AT suhanjung theroleofs100a4forbonemetastasisinprostatecancercells
AT haeminkim theroleofs100a4forbonemetastasisinprostatecancercells
AT junohkwon theroleofs100a4forbonemetastasisinprostatecancercells
AT minkyoungsong theroleofs100a4forbonemetastasisinprostatecancercells
AT minkyungkim theroleofs100a4forbonemetastasisinprostatecancercells
AT hyungjoonkim theroleofs100a4forbonemetastasisinprostatecancercells
AT hongheekim theroleofs100a4forbonemetastasisinprostatecancercells
AT bongjunkim roleofs100a4forbonemetastasisinprostatecancercells
AT suhanjung roleofs100a4forbonemetastasisinprostatecancercells
AT haeminkim roleofs100a4forbonemetastasisinprostatecancercells
AT junohkwon roleofs100a4forbonemetastasisinprostatecancercells
AT minkyoungsong roleofs100a4forbonemetastasisinprostatecancercells
AT minkyungkim roleofs100a4forbonemetastasisinprostatecancercells
AT hyungjoonkim roleofs100a4forbonemetastasisinprostatecancercells
AT hongheekim roleofs100a4forbonemetastasisinprostatecancercells